Biocon Ltd. (BIOCON) Share Price Hits Fresh 52-Week Low at Rs 336.60
- October 21, 2026
- Posted by: Kunal Singla
- Category: News
Biocon Share Price is in focus after the stock touched a fresh 52-week low of Rs 336.60 and was trading at Rs 337.45, down 0.90% on the day, with market capitalisation at Rs 55,491.09 crore. According to latest Univest data, the move places Biocon Ltd. (BIOCON) among the stocks at 52 week low in the current market update. The Biocon Share Price Today action is relevant because it combines a new yearly low with a valuation profile that remains well above the healthcare industry benchmark on earnings multiples. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Biocon Stock News, the key question is not only what happened in price, but what the numbers say about the Biocon Share Price and its underlying fundamental analysis.
Biocon Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 337.45 |
| Previous Close | Rs 340.5 |
| Today's Move | Rs -3.05 (-0.9%) |
| Open | Rs 341 |
| High | Rs 343.85 |
| Low | Rs 336.6 |
| Market Capitalisation | Rs 55,491.09 crore |
Biocon Ltd. (BIOCON) traded at Rs 337.45 versus the previous close of Rs 340.5, a fall of 0.9%. The stock opened at Rs 341, reached a high of Rs 343.85, touched a low of Rs 336.6.
Biocon Share Price Today reflects a narrow intraday range around a fresh 52-week low. The stock opened at Rs 341, touched a high of Rs 343.85 and a low of Rs 336.60, which is also the one-year low and the 52-week trough for the day. It last traded at Rs 337.45 versus the previous close of Rs 340.5, so the day move stands at Rs 3.05 lower, or 0.90%. That keeps Biocon Share Price close to the lower end of the current range while still moving within a relatively tight band. For Biocon Share Price Live tracking, the important point is that the fresh low is confirmed by the day low itself. The price action does not establish a separate reason, so the focus shifts to Biocon Fundamental Analysis and sector context.
In market terms, Biocon Share Price News is being read alongside the company’s valuation and operating ratios rather than any unverified story line. As of 21 October 2026 at 10:52 AM IST, the stock has marked a fresh yearly low and remains one of the notable names in the healthcare space for Stock Market Today watchers.
Biocon Ltd. (BIOCON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 55,491.09 crore |
| P/E Ratio | 112.04x |
| P/B Ratio | 1.63x |
| ROE | 1.35% |
| ROCE | 3.26% |
| EPS | Rs 3.04 |
| Book Value Per Share | Rs 208.53 |
| Dividend Yield | 0.15% |
Biocon Ltd. (BIOCON) fundamental metrics show P/E 112.04x, P/B 1.63x, ROE 1.35%, ROCE 3.26%. These figures provide context only and are not a buy or sell signal.
Biocon Ltd. has a market capitalisation of Rs 55,491.09 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 112.04x, P/B at 1.63x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.57x, median ROE of 11.43%, median ROCE of 13.26%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 112.04x |
| Benchmark Median P/E | 31.57x |
| Benchmark Average P/E | 45.59x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 1.63x |
| Benchmark Median P/B | 2.77x |
| Company ROE | 1.35% |
| Benchmark Median ROE | 11.43% |
| Company ROCE | 3.26% |
| Benchmark Median ROCE | 13.26% |
| Company Market Capitalisation | Rs 55,491.09 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Biocon Ltd. (BIOCON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Biocon Ltd. (BIOCON) has a P/E ratio of 112.04x, which is above the benchmark median of 31.57x, a difference of +254.89%. On its own, the P/E gap is a valuation reference point, not a trading call.
Biocon Ltd. (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.43%, a difference of -88.19%. Biocon Ltd. (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.26%, a difference of -75.41%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Abbott India Ltd. | ABBOTINDIA | 54,909.79 | 34.01 | 10.61 | 34.67 | 46.72 |
| Alkem Laboratories Ltd. | ALKEM | 59,722.72 | 27.68 | 4.17 | 18.29 | 21.28 |
| Gland Pharma Ltd. | GLAND | 49,952.91 | 44.25 | 4.7 | 10.56 | 14.96 |
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 62,339.2 | 34.67 | 5.69 | 14.1 | 20.35 |
| Ipca Laboratories Ltd. | IPCALAB | 46,049.85 | 35.16 | 5.43 | 15.88 | 19.41 |
Biocon Ltd. (BIOCON) has a P/E ratio of 112.04x compared with the displayed peer median of 34.67x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 1.35% compares with a peer median of 15.88% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 20.35%, providing a capital-efficiency comparison. Biocon Ltd. (BIOCON) has a market capitalisation of Rs 55,491.09 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Biocon
- Biocon Share Price touched a fresh 52-week low of Rs 336.60 and is trading near that level.
- The Biocon Share Price Today move came with a 0.90% decline from the previous close of Rs 340.5.
- Biocon Fundamental Analysis shows a P/E of 112.04, well above the same-industry median of 31.57.
- The stock’s P/B of 1.63 is below the sector median of 2.77, which keeps valuation debate active.
- Biocon Share Price sits in Healthcare and Pharmaceuticals & Drugs, where benchmark returns are materially stronger than the company’s ROE and ROCE.
About Biocon Ltd.
Biocon Ltd. is a Healthcare company in the Pharmaceuticals & Drugs industry. The business operates within a large listed universe and is tracked by investors for its earnings profile, valuation ratios and market position. Biocon Share Price reflects a company that is sized at Rs 55,491.09 crore in market capitalisation, while its fundamental profile includes EPS of Rs 3.04, book value of Rs 208.53 per share and dividend yield of 0.15%.
For Biocon Share Price analysis, the business context matters because the stock is evaluated through a mix of company financials, revenue and return ratios. The latest quarter revenue of Rs 4,336 crore for Jun 2026 adds operating context, while the sector comparison shows how the company fits into the broader healthcare and pharmaceutical landscape. Biocon Share Price Today therefore reflects both current market pricing and the company’s position within a competitive industry benchmark.
Track Biocon Share Price on Univest
Use Biocon Ltd. (BIOCON) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors can track Biocon Share Price on Univest for live pricing, market cap, valuation ratios, 52-week levels and company context in one place. Biocon Share Price Live updates help readers follow the latest move, while Biocon Stock News and Biocon Share News keep the focus on verified price action and fundamental analysis. Univest also makes it easier to review Biocon Fundamental Analysis, sector comparison and the current one-year low in a single view.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Biocon Share Price fall today?
Ans. Biocon Share Price fell 0.90% to Rs 337.45 and touched a fresh 52-week low of Rs 336.60. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is the current Biocon Share Price today?
Ans. Biocon Share Price was trading at Rs 337.45, after opening at Rs 341 and touching an intraday low of Rs 336.60. The previous close was Rs 340.5, so the stock was lower by Rs 3.05.
What is the fresh 52-week low for Biocon?
Ans. Biocon Share Price touched a fresh 52-week low of Rs 336.60. That level also matched the day’s low, making it the latest one-year low and the key price reference for the move.
How large is Biocon by market capitalisation?
Ans. Biocon Share Price is backed by a market capitalisation of Rs 55,491.09 crore. That places the company among the larger listed healthcare names, even though the stock is trading near a fresh yearly low.
Is Biocon expensive on valuation?
Ans. Biocon Share Price carries a P/E of 112.04 and a P/B of 1.63. The P/E is far above the same-industry median of 31.57, while the P/B is below the median of 2.77.
What do Biocon’s ROE and ROCE show?
Ans. Biocon Share Price comes with ROE of 1.35% and ROCE of 3.26%. Both are below the same-industry benchmark medians of 11.43% and 13.26%, which adds context to the valuation discussion.
What does Biocon’s book value mean for investors?
Ans. Biocon Share Price has a book value of Rs 208.53 per share. Book value shows the accounting net worth behind each share and is useful when comparing the stock’s P/B ratio with sector peers.
How does Biocon compare with peers?
Ans. Biocon Share Price has a much higher P/E than Abbott India, Alkem Laboratories, Gland Pharma, Glenmark Pharmaceuticals and Ipca Laboratories. Its P/B and return ratios also differ meaningfully from several peers.
Where can investors track Biocon Share Price updates?
Ans. Biocon Share Price updates can be tracked on Univest through live price, market cap, valuation ratios, 52-week levels and company context. That keeps the stock news, fundamentals and sector comparison together in one view.
